Portfolio (Quarterly)
Guide ↗
BML Capital Management, LLC
· CIK 0001616824| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACRS | ACLARIS THERAPEUTICS INC | Healthcare | 14,250,000.0 | $53.4M | 34.31% | — | — | $3.75 | +21.1% |
| 2 | AVIR | ATEA PHARMACEUTICALS INC | Healthcare | 7,058,657.0 | $38.0M | 24.38% | -431K | -5.8% | $5.38 | -21.2% |
| 3 | ORMP | ORAMED PHARMACEUTICALS INC | Healthcare | 3,167,231.0 | $10.8M | 6.91% | — | — | $3.40 | +28.8% |
| 4 | TLYS | TILLYS INC | Consumer Cyclical | 2,150,000.0 | $8.7M | 5.59% | NEW | — | $4.05 | +0.2% |
| 5 | OM | OUTSET MED INC | Healthcare | 1,902,201.0 | $7.3M | 4.69% | +1.4M | +250.2% | $3.84 | +10.9% |
| 6 | PMVP | PMV PHARMACEUTICALS INC | Healthcare | 5,320,000.0 | $6.6M | 4.24% | +28K | +0.5% | $1.24 | +5.6% |
| 7 | KMX | CARMAX INC | Consumer Cyclical | 155,000.0 | $6.4M | 4.14% | — | — | $41.58 | -6.4% |
| 8 | — | KEZAR LIFE SCIENCES INC | — | 720,787.0 | $5.3M | 3.43% | — | — | $7.42 | — |
| 9 | — | INSTIL BIO INC | — | 645,600.0 | $5.3M | 3.42% | — | — | $8.24 | — |
| 10 | TGT | TARGET CORP | Consumer Defensive | 37,500.0 | $4.5M | 2.92% | — | — | $121.20 | +0.9% |
| 11 | KHC | KRAFT HEINZ CO | Consumer Defensive | 125,000.0 | $2.8M | 1.80% | NEW | — | $22.49 | +4.7% |
| 12 | JANX | JANUX THERAPEUTICS INC | Healthcare | 154,961.0 | $2.2M | 1.38% | NEW | — | $13.90 | +3.7% |
| 13 | PLRX | PLIANT THERAPEUTICS INC | Healthcare | 1,546,137.0 | $1.9M | 1.25% | — | — | $1.26 | -4.8% |
| 14 | CNTB | CONNECT BIOPHARMA HLDGS LTD | Healthcare | 408,887.0 | $1.1M | 0.69% | — | — | $2.62 | -9.9% |
| 15 | IMA | IMAGENEBIO INC | Healthcare | 200,730.0 | $1.0M | 0.64% | +24K | +13.4% | $5.00 | +10.4% |
| 16 | WMT PUT | WALMART INC | Consumer Defensive | 335.0 | $329K | 0.21% | — | — | $982.50 | -86.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
84.5%
Consumer Cyclical
10.5%
Consumer Defensive
5.1%